StockWatch
·
Pharmaceuticals
Quarterly Result25 May 2026, 08:57 am

Divis Labs: FY26 Audited Results; ₹30 Dividend Recommended

AI Summary

Divis Laboratories Ltd's board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board recommended a final dividend of ₹30 (1,500%) per equity share of face value ₹2 for FY26, subject to shareholder approval at the AGM on August 10, 2026; record date is July 24, 2026. Standalone revenue from operations stood at ₹2793 Cr for the quarter ended March 31, 2026, and ₹10388 Cr for the year ended March 31, 2026. The Board meeting concluded at 11.50 Hrs.

Key Highlights

  • Audited financial results (standalone and consolidated) approved for FY26.
  • Final dividend of ₹30 per share (1,500%) recommended for FY26.
  • 36th AGM to be held on August 10, 2026; record date for dividend is July 24, 2026.
  • Standalone revenue from operations at ₹10388 Cr for the year ended March 31, 2026.
  • Board meeting commenced at 10.15 Hrs and concluded at 11.50 Hrs.